Porcentaje de ocurrencia de condiciones patog√©nicas:

not provided: 43.41%
not specified: 9.66%
ALG9 congenital disorder of glycosylation: 8.84%
See cases: 8.45%
Inborn genetic diseases: 6.11%
Renal tubular acidosis with progressive nerve deafness: 4.76%
Cutis laxa with osteodystrophy: 4.26%
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss: 4.12%
Autosomal recessive distal renal tubular acidosis: 2.17%
Wrinkly skin syndrome: 0.88%
Developmental and epileptic encephalopathy 93: 0.72%
Cutis Laxa, Recessive: 0.41%
Developmental and epileptic encephalopathy 104: 0.33%
Zimmermann-Laband syndrome 2: 0.29%
Autosomal dominant deafness - onychodystrophy syndrome: 0.27%
Neurodevelopmental disorder with epilepsy and brain atrophy: 0.27%
ATP6V0A2-related disorder: 0.16%
Meckel syndrome, type 8: 0.14%
Joubert syndrome 24: 0.14%
Meckel-Gruber syndrome: 0.12%
Autosomal recessive cutis laxa type 2D: 0.12%
ATP6V1B2-related disorder: 0.12%
Epilepsy, early-onset, 3, with or without developmental delay: 0.12%
Neurodevelopmental disorder: 0.12%
Joubert syndrome: 0.12%
ATP6V0A4-related disorder: 0.12%
Breast ductal adenocarcinoma: 0.12%
Global developmental delay: 0.10%
ATP6V1B1-related disorder: 0.10%
ATP6V1A-related disorder: 0.10%
Cutis laxa: 0.08%
Early infantile epileptic encephalopathy with suppression bursts: 0.08%
Polydactyly: 0.08%
Seizure: 0.08%
Autosomal recessive cutis laxa type 2C: 0.06%
Hypertrophic cardiomyopathy 26: 0.06%
Dilated Cardiomyopathy, Dominant: 0.06%
Distal renal tubular acidosis: 0.06%
Ring chromosome 7: 0.06%
Mosaic trisomy 2: 0.06%
Atrial septal defect 7: 0.06%
EPILEPSY, EARLY-ONSET, 3, WITH DEVELOPMENTAL DELAY: 0.06%
Chromosome 3q13.31 deletion syndrome: 0.06%
Chromosome 22q11.2 microduplication syndrome: 0.06%
Myofibrillar myopathy 5: 0.06%
Distal myopathy with posterior leg and anterior hand involvement: 0.06%
Intellectual disability, mild: 0.04%
Pleomorphic xanthoastrocytoma: 0.04%
ATP6V0A1-related condition: 0.04%
Microcephaly: 0.04%
Vasculitis due to ADA2 deficiency: 0.04%
Hereditary nonpolyposis colorectal neoplasms: 0.04%
Autosomal dominant limb-girdle muscular dystrophy type 1F: 0.04%
Poly (ADP-Ribose) polymerase inhibitor response: 0.04%
Cat eye syndrome: 0.04%
Megacolon: 0.04%
Autism: 0.04%
Hearing impairment: 0.04%
Neurodevelopmental delay: 0.04%
Hyperaldosteronism, familial, type IV: 0.04%
Epilepsy: 0.04%
Abnormal facial shape: 0.04%
Idiopathic generalized epilepsy: 0.04%
Hypotonia: 0.04%
Esophageal atresia: 0.02%
Breast-ovarian cancer, familial, susceptibility to, 1: 0.02%
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures: 0.02%
Deficiency of butyryl-CoA dehydrogenase: 0.02%
Severe short stature: 0.02%
Intellectual disability: 0.02%
Pyloric stenosis: 0.02%
Cerebellar ataxia: 0.02%
Prostate cancer: 0.02%
Focal-onset seizure: 0.02%
Chromosome 16q12 duplication syndrome: 0.02%
Partial trisomy of the long arm of chromosome 16: 0.02%
Hemimegalencephaly: 0.02%
Chromosome 16p13.3 duplication syndrome: 0.02%
Childhood-onset epilepsy syndrome: 0.02%
Saldino-Mainzer syndrome: 0.02%
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome: 0.02%
Autosomal dominant nonsyndromic hearing loss 65: 0.02%
Caused by mutation in the TBC1 domain family, member 24: 0.02%
Developmental and epileptic encephalopathy, 1: 0.02%
Floppy infant: 0.02%
Renal transitional cell carcinoma: 0.02%
Bailey-Bloch congenital myopathy: 0.02%
Distal Renal Tubular Acidosis, Recessive: 0.02%
Bilateral polymicrogyria: 0.02%
Charcot-Marie-Tooth disease dominant intermediate C: 0.02%
Small face: 0.02%
Growth delay: 0.02%
Hypertelorism: 0.02%
Wide mouth: 0.02%
Short finger: 0.02%
Sensorineural hearing loss disorder: 0.02%
Lower limb spasticity: 0.02%
Severe global developmental delay: 0.02%
Large for gestational age: 0.02%
Cerebral visual impairment and intellectual disability: 0.02%
Developmental and epileptic encephalopathy, 2: 0.02%
Developmental disorder: 0.02%
Neurodevelopmental abnormality: 0.02%
Encephalopathy: 0.02%
Abnormal esophagus morphology: 0.02%
Dyskeratosis congenita, autosomal dominant 6: 0.02%
ATP6V1B2 related neurodevelopmental disorders: 0.02%
Hereditary spastic paraplegia 53: 0.02%
8p inverted duplication/deletion syndrome: 0.02%
Nephrocalcinosis: 0.02%
Rare genetic deafness: 0.02%
Abnormality of the genitourinary system: 0.02%
Usher syndrome: 0.02%
Polydactyly, postaxial, type A1: 0.02%
Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency: 0.02%
5q35 microduplication syndrome: 0.02%
Hunter-McAlpine craniosynostosis: 0.02%
Abnormal fetal cardiovascular morphology: 0.02%
Narrow forehead: 0.02%
Wide nasal bridge: 0.02%
Micrognathia: 0.02%
Zimmermann-Laband syndrome with epileptic encephalopathy: 0.02%
Anomalous pulmonary venous return: 0.02%
Leber congenital amaurosis 13: 0.02%
14q22.2q24.3 duplication: 0.02%
Cohen syndrome: 0.02%
Zimmermann-Laband syndrome 1: 0.02%
DOORS syndrome: 0.02%
Low-set ears: 0.02%
Delayed speech and language development: 0.02%
Delayed fine motor development: 0.02%
Immunodeficiency 51: 0.02%
RASopathy: 0.02%
Distal tetrasomy 15q: 0.02%
Proteasome-associated autoinflammatory syndrome 1: 0.02%
Parathyroid carcinoma: 0.02%
Paragangliomas 3: 0.02%
Gastrointestinal stromal tumor: 0.02%
